The United States Department of Justice on 23 June announced criminal charges against 455 defendants in a two-week operation spanning 45 states and territories, accusing them of attempting to defraud public healthcare programmes of more than $6.5bn. Acting Attorney General Todd Blanche characterised it as “the greatest combined federal and state effort in combating healthcare fraud in history.” According to officials, the sweep—executed by 46 anti-fraud strike forces—seized roughly $127m in cash, luxury vehicles, jewellery, and other assets purchased with stolen public money.

From the perspective of federal prosecutors in Washington, the alleged schemes illustrate a systemic exploitation of Medicare and Medicaid. Among the accused are a Los Angeles-area hospice owner accused of paying kickbacks for enrolling people who were not terminally ill, generating nearly $27m in false claims; a Florida cardiologist charged with billing $89m for unnecessary cardiovascular screenings of student athletes and then certifying results without review; and a Texas nurse practitioner who allegedly used proceeds from fraudulent wound-care claims on luxury cars and jewellery. Officials also announced the expansion of the FBI’s “Most Wanted Fraudsters” list with two international fugitives—one linked to a $547m genetic-testing conspiracy, the other to a $95m laboratory billing scheme—who are believed to have fled to the United Arab Emirates and Vietnam, respectively.

Analysts in Washington note that the Trump administration is deploying new data-sharing agreements to shift from a reactive “pay and chase” model to proactive detection. The Justice Department revealed a memorandum of understanding with the Federal Trade Commission to access consumer complaints about telemarketing fraud, and an arrangement with the Department of Homeland Security to track travel patterns of providers suspected of billing fraud. Health Secretary Robert F. Kennedy Jr. and Medicare administrator Mehmet Oz stressed that artificial intelligence and advanced data analytics are now used to block suspect claims before disbursement. This interagency approach echoes similar enforcement drives: the Department of Labor recently threatened states with loss of federal funding unless they strengthened fraud controls in unemployment insurance, and a 2023 Small Business Administration report estimated that $200bn—about 17% of pandemic business aid—may have been lost to fraudulent actors.

Viewed from state-level constituencies, however, the federal campaign carries political contours. Critics, as reported in the Moscow-based newspaper Kommersant, argue that some operations appear to disproportionately target programmes such as Medicaid and jurisdictions that vote Democratic—echoing a long-standing conservative ambition to shrink those programmes. Administration officials deny political motive, framing the crackdown as a defence of taxpayer money. The sweep also coincides with a separate civil settlement: a federal court is scheduled to give final approval on 20 August 2026 to a $35m class-action settlement with Laboratory Corp of America over a 2018–2019 data breach that exposed medical information of 7.7 million people, entitling them to payments of up to $5,000. Charges unsealed since 8 June signal that the Department of Justice intends to maintain its enhanced investigative tempo into 2026.